Literature DB >> 18221476

Oral desensitization in children with immunoglobulin E-mediated cow's milk allergy--follow-up at 4 yr and 8 months.

Paolo Meglio1, Paolo G Giampietro, Simona Gianni, Elena Galli.   

Abstract

Until now, the basic treatment for food allergy has been to avoid the offending item. This approach is difficult in the case of common foods and in the case where there is a risk of severe reaction after consuming the offending food, even inadvertently. This is the follow-up of a previous study aimed at desensitizing 21 children with immunoglobulin E (IgE)-mediated cow's milk (CM) allergy. This protocol was totally or partially successful in 85% of cases, but failed in the remaining 15%. Our aims were to study the long-term effectiveness and safety of oral CM desensitization, and the prognostic value of Skin Prick Test (SPT) and specific serum CM IgE. The 21 children were called back (one dropped out). The allergic history and other information on CM intake over the last 4-5 yr were recorded. Children underwent SPT, and end-point SPT, with casein and alpha-lactoalbumin. Specific CM IgE was also measured. At follow-up, 14/20 children totally (n = 13, 65%) or partially (n = 1, 5%) tolerated CM. None of the recalled children reported use of emergency care. SPT positivity to casein and/or alpha-lactoalbumin decreased significantly (p < 0.01), and all the negative SPT referred to the tolerant children. Cutaneous sensitivity to both casein and alpha-lactoalbumin (end-point SPT) significantly decreased after the 6-month desensitization period of the previous study (p < 0.001), but did not decrease significantly at follow-up. A significant reduction of serum-specific CM IgE was also observed (p < 0.05). Clinical tolerance induced by oral CM desensitization persists in time. Negativization of SPT and reduction of specific CM IgE could be considered prognostic indicators of CM tolerance. Oral CM desensitization seems to be a promising method to treat CM food allergy. This protocol is time-consuming but offers the advantage that it can be performed at home. This methodology must only be used by trained staff.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18221476     DOI: 10.1111/j.1399-3038.2007.00670.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  20 in total

1.  Long-term follow-up of oral immunotherapy for cow's milk allergy.

Authors:  Corinne A Keet; Shannon Seopaul; Sarah Knorr; Satya Narisety; Justin Skripak; Robert A Wood
Journal:  J Allergy Clin Immunol       Date:  2013-06-25       Impact factor: 10.793

Review 2.  Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.

Authors:  Amy M Scurlock
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

Review 3.  The Heterogeneity of Oral Immunotherapy Clinical Trials: Implications and Future Directions.

Authors:  Christina S K Yee; Rima Rachid
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806

Review 4.  Immunotherapy in food allergy.

Authors:  Toral Kamdar; Paul J Bryce
Journal:  Immunotherapy       Date:  2010-05       Impact factor: 4.196

Review 5.  Immunological mechanisms for desensitization and tolerance in food allergy.

Authors:  Rima Rachid; Dale T Umetsu
Journal:  Semin Immunopathol       Date:  2012-07-21       Impact factor: 9.623

Review 6.  Emerging therapies for food allergy.

Authors:  Corinne A Keet; Robert A Wood
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

Review 7.  Sublingual (SLIT) versus oral immunotherapy (OIT) for food allergy.

Authors:  Emily C McGowan; Robert A Wood
Journal:  Curr Allergy Asthma Rep       Date:  2014-12       Impact factor: 4.806

8.  Predicting development of sustained unresponsiveness to milk oral immunotherapy using epitope-specific antibody binding profiles.

Authors:  Mayte Suárez-Fariñas; Maria Suprun; Helena L Chang; Gustavo Gimenez; Galina Grishina; Robert Getts; Kari Nadeau; Robert A Wood; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2018-12-07       Impact factor: 10.793

9.  New modalities of allergen immunotherapy.

Authors:  Manish Ramesh; Merhunisa Karagic
Journal:  Hum Vaccin Immunother       Date:  2018-09-14       Impact factor: 3.452

10.  Oral desensitization to milk: how to choose the starting dose!

Authors:  Francesca Mori; Neri Pucci; Maria Elisabetta Rossi; Maurizio de Martino; Chiara Azzari; Elio Novembre
Journal:  Pediatr Allergy Immunol       Date:  2009-07-13       Impact factor: 6.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.